Trousseau's syndrome triggered by an immune checkpoint blockade in a non‐small cell lung cancer patient

Abstract excerpt

PD-1 blockade therapy activates T cells by blocking the interaction between PD-1 and PD-L1 and promotes IFN-γ and Th1 cytokine production. In turn, IFN-γ and Th1 cytokines produced by activated T cells promote TF synthesis in monocytes/macrophages, which results in hypercoagulability leading to thrombosis.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Brain Metastases and Treatment
• Share to Cancer Immunotherapy and Biomarkers
• Share to Cell Adhesion Molecules Research